Genetic engineering between therapeutic necessity and legal liability
DOI:
https://doi.org/10.54172/fdqdt862Keywords:
genetic engineering, therapeutic, genetic diseases, interestsAbstract
This study is based on shedding light on a contemporary legal issue that emerged as a result of medical and scientific progress that rose to the extent of finding means through which to prevent the occurrence of some diseases, repair body errors, as well as resist hereditary microbial diseases. Despite the great importance and benefits of genetic engineering and its success in treating diseases, it carries some danger. This study aims to try to reconcile all interests, as treatment with genetic engineering revolves around two things: the human interest in treating genetic diseases, and the community interest in protecting its members from taking them as a field for experiments. This study relied on the analytical approach and this study showed that in order for genetic engineering to be legitimate, it must have a therapeutic purpose. This study also recommended to the Libyan legislator the need to set strict texts regarding the accountability of those who perform genetic engineering treatment operations with a non-therapeutic intent, and recommended the necessity of establishing research centers in the field of genetic engineering whose orientations are compatible with the provisions of Islamic law.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Salma Jaber Saeid (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright of the articles Published by Almukhtar Journal of Social Science (MJSSc) is retained by the author(s), who grant MJSc a license to publish the article. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors and cite MJSSc as the original publisher. Also, they accept the article remains published by the MJSSc website (except in the occasion of a retraction of the article).





